In vitro toxic evaluation of two gliptins and their main impurities of synthesis

Detalhes bibliográficos
Autor(a) principal: Giordani, Camila Ferrazza Alves
Data de Publicação: 2019
Outros Autores: Campanharo, Sarah Chagas, Wingert, Nathalie Ribeiro, Bueno, Lívia Maronesi, Manoel, Joanna Wittckind, Costa, Bárbara Souza da, Cattani, Shanda Aparecida, Arbo, Marcelo Dutra, Garcia, Solange Cristina, Garcia, Cassia Virginia, Volpato, Nadia Maria, Schapoval, Elfrides Eva Scherman, Steppe, Martin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/205991
Resumo: Background: The presence of impurities in some drugs may compromise the safety and efficacy of the patient’s treatment. Therefore, establishing of the biological safety of the impurities is essential. Diabetic patients are predisposed to tissue damage due to an increased oxidative stress process; and drug impurities may contribute to these toxic effects. In this context, the aim of this work was to study the toxicity, in 3 T3 cells, of the antidiabetic agents sitagliptin, vildagliptin, and their two main impurities of synthesis (S1 and S2; V1 and V2, respectively). Methods: MTT reduction and neutral red uptake assays were performed in cytotoxicity tests. In addition, DNA damage (measured by comet assay), intracellular free radicals (by DCF), NO production, and mitochondrial membrane potential (ΔψM) were evaluated. Results: Cytotoxicity was observed for impurity V2. Free radicals generation was found at 1000 μM of sitagliptin and 10 μM of both vildagliptin impurities (V1 and V2). A decrease in NO production was observed for all vildagliptin concentrations. No alterations were observed in ΔψM or DNA damage at the tested concentrations. Conclusions: This study demonstrated that the presence of impurities might increase the cytotoxicity and oxidative stress of the pharmaceutical formulations at the concentrations studied.
id UFRGS-2_172bddce7bb83e67ab9a9e8d70d66c2c
oai_identifier_str oai:www.lume.ufrgs.br:10183/205991
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Giordani, Camila Ferrazza AlvesCampanharo, Sarah ChagasWingert, Nathalie RibeiroBueno, Lívia MaronesiManoel, Joanna WittckindCosta, Bárbara Souza daCattani, Shanda AparecidaArbo, Marcelo DutraGarcia, Solange CristinaGarcia, Cassia VirginiaVolpato, Nadia MariaSchapoval, Elfrides Eva SchermanSteppe, Martin2020-02-15T04:20:24Z20192050-6511http://hdl.handle.net/10183/205991001112186Background: The presence of impurities in some drugs may compromise the safety and efficacy of the patient’s treatment. Therefore, establishing of the biological safety of the impurities is essential. Diabetic patients are predisposed to tissue damage due to an increased oxidative stress process; and drug impurities may contribute to these toxic effects. In this context, the aim of this work was to study the toxicity, in 3 T3 cells, of the antidiabetic agents sitagliptin, vildagliptin, and their two main impurities of synthesis (S1 and S2; V1 and V2, respectively). Methods: MTT reduction and neutral red uptake assays were performed in cytotoxicity tests. In addition, DNA damage (measured by comet assay), intracellular free radicals (by DCF), NO production, and mitochondrial membrane potential (ΔψM) were evaluated. Results: Cytotoxicity was observed for impurity V2. Free radicals generation was found at 1000 μM of sitagliptin and 10 μM of both vildagliptin impurities (V1 and V2). A decrease in NO production was observed for all vildagliptin concentrations. No alterations were observed in ΔψM or DNA damage at the tested concentrations. Conclusions: This study demonstrated that the presence of impurities might increase the cytotoxicity and oxidative stress of the pharmaceutical formulations at the concentrations studied.application/pdfengBMC pharmacology and toxicology. London. Vol. 20, Supl. 1 (2019), 82, [9 p.]FarmáciaFosfato de sitagliptinaVildagliptinaCitotoxicidadeEstresse oxidativoIn vitro toxic evaluation of two gliptins and their main impurities of synthesisEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001112186.pdf.txt001112186.pdf.txtExtracted Texttext/plain35933http://www.lume.ufrgs.br/bitstream/10183/205991/2/001112186.pdf.txt25e873f075c0b74c77ccaa7e382cd44cMD52ORIGINAL001112186.pdfTexto completo (inglês)application/pdf1905667http://www.lume.ufrgs.br/bitstream/10183/205991/1/001112186.pdf126134e4a541d8a3ee8e1bc6fd2258a7MD5110183/2059912020-02-16 04:16:39.835098oai:www.lume.ufrgs.br:10183/205991Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2020-02-16T07:16:39Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv In vitro toxic evaluation of two gliptins and their main impurities of synthesis
title In vitro toxic evaluation of two gliptins and their main impurities of synthesis
spellingShingle In vitro toxic evaluation of two gliptins and their main impurities of synthesis
Giordani, Camila Ferrazza Alves
Farmácia
Fosfato de sitagliptina
Vildagliptina
Citotoxicidade
Estresse oxidativo
title_short In vitro toxic evaluation of two gliptins and their main impurities of synthesis
title_full In vitro toxic evaluation of two gliptins and their main impurities of synthesis
title_fullStr In vitro toxic evaluation of two gliptins and their main impurities of synthesis
title_full_unstemmed In vitro toxic evaluation of two gliptins and their main impurities of synthesis
title_sort In vitro toxic evaluation of two gliptins and their main impurities of synthesis
author Giordani, Camila Ferrazza Alves
author_facet Giordani, Camila Ferrazza Alves
Campanharo, Sarah Chagas
Wingert, Nathalie Ribeiro
Bueno, Lívia Maronesi
Manoel, Joanna Wittckind
Costa, Bárbara Souza da
Cattani, Shanda Aparecida
Arbo, Marcelo Dutra
Garcia, Solange Cristina
Garcia, Cassia Virginia
Volpato, Nadia Maria
Schapoval, Elfrides Eva Scherman
Steppe, Martin
author_role author
author2 Campanharo, Sarah Chagas
Wingert, Nathalie Ribeiro
Bueno, Lívia Maronesi
Manoel, Joanna Wittckind
Costa, Bárbara Souza da
Cattani, Shanda Aparecida
Arbo, Marcelo Dutra
Garcia, Solange Cristina
Garcia, Cassia Virginia
Volpato, Nadia Maria
Schapoval, Elfrides Eva Scherman
Steppe, Martin
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Giordani, Camila Ferrazza Alves
Campanharo, Sarah Chagas
Wingert, Nathalie Ribeiro
Bueno, Lívia Maronesi
Manoel, Joanna Wittckind
Costa, Bárbara Souza da
Cattani, Shanda Aparecida
Arbo, Marcelo Dutra
Garcia, Solange Cristina
Garcia, Cassia Virginia
Volpato, Nadia Maria
Schapoval, Elfrides Eva Scherman
Steppe, Martin
dc.subject.por.fl_str_mv Farmácia
Fosfato de sitagliptina
Vildagliptina
Citotoxicidade
Estresse oxidativo
topic Farmácia
Fosfato de sitagliptina
Vildagliptina
Citotoxicidade
Estresse oxidativo
description Background: The presence of impurities in some drugs may compromise the safety and efficacy of the patient’s treatment. Therefore, establishing of the biological safety of the impurities is essential. Diabetic patients are predisposed to tissue damage due to an increased oxidative stress process; and drug impurities may contribute to these toxic effects. In this context, the aim of this work was to study the toxicity, in 3 T3 cells, of the antidiabetic agents sitagliptin, vildagliptin, and their two main impurities of synthesis (S1 and S2; V1 and V2, respectively). Methods: MTT reduction and neutral red uptake assays were performed in cytotoxicity tests. In addition, DNA damage (measured by comet assay), intracellular free radicals (by DCF), NO production, and mitochondrial membrane potential (ΔψM) were evaluated. Results: Cytotoxicity was observed for impurity V2. Free radicals generation was found at 1000 μM of sitagliptin and 10 μM of both vildagliptin impurities (V1 and V2). A decrease in NO production was observed for all vildagliptin concentrations. No alterations were observed in ΔψM or DNA damage at the tested concentrations. Conclusions: This study demonstrated that the presence of impurities might increase the cytotoxicity and oxidative stress of the pharmaceutical formulations at the concentrations studied.
publishDate 2019
dc.date.issued.fl_str_mv 2019
dc.date.accessioned.fl_str_mv 2020-02-15T04:20:24Z
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/205991
dc.identifier.issn.pt_BR.fl_str_mv 2050-6511
dc.identifier.nrb.pt_BR.fl_str_mv 001112186
identifier_str_mv 2050-6511
001112186
url http://hdl.handle.net/10183/205991
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv BMC pharmacology and toxicology. London. Vol. 20, Supl. 1 (2019), 82, [9 p.]
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/205991/2/001112186.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/205991/1/001112186.pdf
bitstream.checksum.fl_str_mv 25e873f075c0b74c77ccaa7e382cd44c
126134e4a541d8a3ee8e1bc6fd2258a7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224986607747072